145 related articles for article (PubMed ID: 28765339)
1. Use of Calcium Channel Blockers and Breast Cancer Risk in the Women's Health Initiative.
Brasky TM; Krok-Schoen JL; Liu J; Chlebowski RT; Freudenheim JL; Lavasani S; Margolis KL; Qi L; Reding KW; Shields PG; Simon MS; Wactawski-Wende J; Wang A; Womack C; Manson JE
Cancer Epidemiol Biomarkers Prev; 2017 Aug; 26(8):1345-1348. PubMed ID: 28765339
[No Abstract] [Full Text] [Related]
2. Calcium channel blockers for people with chronic kidney disease requiring dialysis.
Mugendi GA; Mutua FM; Natale P; Esterhuizen TM; Strippoli GF
Cochrane Database Syst Rev; 2020 Oct; 10(10):CD011064. PubMed ID: 33000470
[TBL] [Abstract][Full Text] [Related]
3. Antihypertensive agents and the risk of breast cancer in women aged 55 years and older: a nested case-control study.
Chang CH; Chiang CH; Yen CJ; Wu LC; Lin JW; Lai MS
J Hypertens; 2016 Mar; 34(3):558-66; discussion 566. PubMed ID: 26818924
[TBL] [Abstract][Full Text] [Related]
4. The Association of the C-Reactive Protein Inflammatory Biomarker with Breast Cancer Incidence and Mortality in the Women's Health Initiative.
Nelson SH; Brasky TM; Patterson RE; Laughlin GA; Kritz-Silverstein D; Edwards BJ; Lane D; Rohan TE; Ho GYF; Manson JE; LaCroix AZ
Cancer Epidemiol Biomarkers Prev; 2017 Jul; 26(7):1100-1106. PubMed ID: 28292922
[No Abstract] [Full Text] [Related]
5. Calcium channel blockers for inhibiting preterm labour and birth.
Flenady V; Wojcieszek AM; Papatsonis DN; Stock OM; Murray L; Jardine LA; Carbonne B
Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD002255. PubMed ID: 24901312
[TBL] [Abstract][Full Text] [Related]
6. Calcium channel blockers for primary and secondary Raynaud's phenomenon.
Rirash F; Tingey PC; Harding SE; Maxwell LJ; Tanjong Ghogomu E; Wells GA; Tugwell P; Pope J
Cochrane Database Syst Rev; 2017 Dec; 12(12):CD000467. PubMed ID: 29237099
[TBL] [Abstract][Full Text] [Related]
7. Use of Antihypertensive Medications and Risk of Adverse Breast Cancer Outcomes in a SEER-Medicare Population.
Chen L; Chubak J; Boudreau DM; Barlow WE; Weiss NS; Li CI
Cancer Epidemiol Biomarkers Prev; 2017 Nov; 26(11):1603-1610. PubMed ID: 28807926
[No Abstract] [Full Text] [Related]
8. Relation between use of antihypertensive medications and risk of breast carcinoma among women ages 65-79 years.
Li CI; Malone KE; Weiss NS; Boudreau DM; Cushing-Haugen KL; Daling JR
Cancer; 2003 Oct; 98(7):1504-13. PubMed ID: 14508839
[TBL] [Abstract][Full Text] [Related]
9. Racial/ethnic differences in use and duration of adjuvant hormonal therapy for breast cancer in the women's health initiative.
Livaudais JC; Lacroix A; Chlebowski RT; Li CI; Habel LA; Simon MS; Thompson B; Erwin DO; Hubbell FA; Coronado GD
Cancer Epidemiol Biomarkers Prev; 2013 Mar; 22(3):365-73. PubMed ID: 23275187
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular Outcomes in Relation to Antihypertensive Medication Use in Women with and Without Cancer: Results from the Women's Health Initiative.
Reding KW; Aragaki AK; Cheng RK; Barac A; Wassertheil-Smoller S; Chubak J; Limacher MC; Hundley WG; D'Agostino R; Vitolins MZ; Brasky TM; Habel LA; Chow EJ; Jackson RD; Chen C; Morgenroth A; Barrington WE; Banegas M; Barnhart M; Chlebowski RT
Oncologist; 2020 Aug; 25(8):712-721. PubMed ID: 32250503
[TBL] [Abstract][Full Text] [Related]
11. Calcium Channel Blockers and the Risk for Lung Cancer: A Population-Based Nested Case-Control Study.
Rotshild V; Azoulay L; Feldhamer I; Perlman A; Glazer M; Muszkat M; Matok I
Ann Pharmacother; 2019 May; 53(5):445-452. PubMed ID: 30442036
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin-converting enzyme inhibitors, calcium channel blockers, and breast cancer.
Meier CR; Derby LE; Jick SS; Jick H
Arch Intern Med; 2000 Feb; 160(3):349-53. PubMed ID: 10668837
[TBL] [Abstract][Full Text] [Related]
13. Calcium channel blockers are associated with lower gastric cancer risk: A territory-wide study with propensity score analysis.
Li B; Cheung KS; Wong IY; Leung WK; Law S
Int J Cancer; 2021 May; 148(9):2148-2157. PubMed ID: 33152125
[TBL] [Abstract][Full Text] [Related]
14. Periodontal Disease and Incident Cancer Risk among Postmenopausal Women: Results from the Women's Health Initiative Observational Cohort.
Nwizu NN; Marshall JR; Moysich K; Genco RJ; Hovey KM; Mai X; LaMonte MJ; Freudenheim JL; Wactawski-Wende J
Cancer Epidemiol Biomarkers Prev; 2017 Aug; 26(8):1255-1265. PubMed ID: 28765338
[No Abstract] [Full Text] [Related]
15. Cardiometabolic risk factors and survival after cancer in the Women's Health Initiative.
Simon MS; Hastert TA; Barac A; Banack HR; Caan BJ; Chlebowski RT; Foraker R; Hovsepyan G; Liu S; Luo J; Manson JE; Neuhouser ML; Okwuosa TM; Pan K; Qi L; Ruterbusch JJ; Shadyab AH; Thomson CA; Wactawski-Wende J; Waheed N; Beebe-Dimmer JL
Cancer; 2021 Feb; 127(4):598-608. PubMed ID: 33151547
[TBL] [Abstract][Full Text] [Related]
16. Comparative Effectiveness of Renin-Angiotensin System Inhibitors and Calcium Channel Blockers in Individuals With Advanced CKD: A Nationwide Observational Cohort Study.
Fu EL; Clase CM; Evans M; Lindholm B; Rotmans JI; Dekker FW; van Diepen M; Carrero JJ
Am J Kidney Dis; 2021 May; 77(5):719-729.e1. PubMed ID: 33246024
[TBL] [Abstract][Full Text] [Related]
17. Antidepressant Use and Risk of Colorectal Cancer in the Women's Health Initiative.
Kiridly-Calderbank JF; Sturgeon SR; Kroenke CH; Reeves KW
Cancer Epidemiol Biomarkers Prev; 2018 Aug; 27(8):892-898. PubMed ID: 29789327
[No Abstract] [Full Text] [Related]
18. Verification of the effects of calcium channel blockers on the immune microenvironment of breast cancer.
Takada K; Kashiwagi S; Asano Y; Goto W; Takahashi K; Fujita H; Takashima T; Tomita S; Hirakawa K; Ohira M
BMC Cancer; 2019 Jun; 19(1):615. PubMed ID: 31234828
[TBL] [Abstract][Full Text] [Related]
19. Treatment of angina pectoris with calcium antagonists: long-term follow-up.
Behar S
Cardiovasc Drugs Ther; 1998 Apr; 12 Suppl 1():119-24. PubMed ID: 9642485
[TBL] [Abstract][Full Text] [Related]
20. Use of calcium channel blockers and breast carcinoma risk in postmenopausal women.
Fitzpatrick AL; Daling JR; Furberg CD; Kronmal RA; Weissfeld JL
Cancer; 1997 Oct; 80(8):1438-47. PubMed ID: 9338468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
